Cargando…

Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future

Diabetic kidney disease (DKD) is a leading cause of morbidity and mortality among people living with diabetes, and is one of the most important causes of end stage renal disease worldwide. In order to reduce progression of DKD, important management goals include treatment of hypertension, glycaemia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mallik, Ritwika, Chowdhury, Tahseen A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Diabetic Kidney Disease: Pathogenesis and Therapeutic Targets
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905210/ https://www.ncbi.nlm.nih.gov/pubmed/35281302 http://dx.doi.org/10.1177/20420188221081601

Ejemplares similares

Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes
por: de Bhailís, Áine M., et al.
Publicado: (2021)

Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetes
por: Buyadaa, Oyunchimeg, et al.
Publicado: (2022)

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice
por: von Scholten, Bernt Johan, et al.
Publicado: (2022)

Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China
por: Liu, Yazhuo, et al.
Publicado: (2022)

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?
por: Ujjawal, Aditi, et al.
Publicado: (2022)

Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view
por: Pinier, Cédric, et al.
Publicado: (2019)

Sodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing
por: Li, Jiahua, et al.
Publicado: (2019)

Diabetic nephropathy as the cause of end-stage kidney disease reported on the medical evidence form CMS2728 at a single center
por: Yuan, Christina M., et al.
Publicado: (2017)

The large spectrum of renal disease in diabetic patients
por: Bermejo, Sheila, et al.
Publicado: (2017)

Diabetes mellitus: a single cardiorenal syndrome umbrella
por: Rodríguez, Eva, et al.
Publicado: (2019)

The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?
por: Sarafidis, Pantelis A, et al.
Publicado: (2019)

Diabetes, deafness and renal disease
por: Godinho, Iolanda, et al.
Publicado: (2017)

Perspectives of a proposed patient navigator programme for people with chronic kidney disease in rural communities: Report from national workshops
por: Scholes‐Robertson, Nicole, et al.
Publicado: (2022)

Novel Pharmacotherapies in Diabetic Retinopathy
por: Dedania, Vaidehi S., et al.
Publicado: (2015)

Long-term outcome in inherited nephrogenic diabetes insipidus
por: Sharma, Sonia, et al.
Publicado: (2018)

Case Report: Absence of Clinically Significant Recurrent Diabetic Kidney Disease on Postmortem Biopsy 32 Years After Kidney Transplantation for Type 1 Diabetes
por: Nicholl, David D. M., et al.
Publicado: (2021)

Rare diseases, rare presentations: recognizing atypical inherited kidney disease phenotypes in the age of genomics
por: Ars, Elisabet, et al.
Publicado: (2017)

Kidney Donors With Diabetes: Renal Biopsy Findings at Time of Transplantation and Their Significance
por: Truong, Luan D., et al.
Publicado: (2019)

Early Treatment With Olmesartan Prevents Juxtamedullary Glomerular Podocyte Injury and the Onset of Microalbuminuria in Type 2 Diabetic Rats
por: Sofue, Tadashi, et al.
Publicado: (2012)

Chronic kidney disease in children
por: Becherucci, Francesca, et al.
Publicado: (2016)

Octreotide Delaying the Progression of Recurrent IgA Nephropathy After Kidney Transplantation
por: Sharma, Akhil, et al.
Publicado: (2019)

Potential and pitfalls in the genetic diagnosis of kidney diseases
por: Kesselheim, Anne, et al.
Publicado: (2017)

Electronic patient-reported outcomes in clinical kidney practice (ePRO Kidney): a process evaluation of educational support for clinicians
por: Schick-Makaroff, Kara, et al.
Publicado: (2023)

Consequences of morbid obesity on the kidney. Where are we going?
por: Navarro Díaz, Maruja
Publicado: (2016)

HIV and kidney diseases: 35 years of history and consequences
por: Campos, Pedro, et al.
Publicado: (2016)

Incident chronic kidney disease: trends in management and outcomes
por: Perkins, Robert M., et al.
Publicado: (2016)

The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients
por: Kukla, Aleksandra, et al.
Publicado: (2020)

How Should We Think About the Role of the Brain in Glucose Homeostasis and Diabetes?
por: Deem, Jennifer D., et al.
Publicado: (2017)

Chronic kidney disease hotspots in developing countries in South Asia
por: Abraham, Georgi, et al.
Publicado: (2016)

Pharmacotherapies for Diabetic Retinopathy: Present and Future
por: Schwartz, Stephen G., et al.
Publicado: (2007)

Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021)

Development and Validation of a New Score to Assess the Risk of Posttransplantation Diabetes Mellitus in Kidney Transplant Recipients
por: Serna-Higuita, Lina Maria, et al.
Publicado: (2023)

Artificial Pancreas: Past, Present, Future
por: Cobelli, Claudio, et al.
Publicado: (2011)

Impact of routine reporting of estimated glomerular filtration rate using the European Kidney Function Consortium and Chronic Kidney Disease Epidemiology Collaboration equations in a Western Australian community population
por: Napier, Kathryn, et al.
Publicado: (2022)

Patient kidney disease knowledge remains inadequate with standard nephrology outpatient care
por: Gray, Nicholas A., et al.
Publicado: (2016)

Safety concerns about intravenous iron therapy in patients with chronic kidney disease
por: Del Vecchio, Lucia, et al.
Publicado: (2016)

Noninvasive markers of arterial stiffness and renal outcomes in patients with chronic kidney disease
por: Guo, Xinru, et al.
Publicado: (2021)

Chronic kidney disease in public renal practices in Queensland, Australia, 2011–2018
por: Hoy, Wendy E., et al.
Publicado: (2022)

High prevalence of chronic kidney disease in a semi-urban population of Western India
por: Trivedi, Hargovind, et al.
Publicado: (2016)

Chronic kidney disease: Definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk
por: Wilson, Scott, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jvn5hj4atl9im0o4fknccfl4fj